Angitia Biopharmaceuticals
Innovation for Patients
Westlake Village, United States · Founded 2018 · $420.0M raised
- Headquarters
- Westlake Village, California
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- angitiabio.com
- Total Funding
- $420.0M
- Last Round
- $130.0M Series DFeb 2026
- Rounds
- 5
About
Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on discovering and developing innovative therapeutics for musculoskeletal diseases including osteoporosis, osteogenesis imperfecta, and spinal fusion. The company's pipeline features bispecific antibody candidates in Phase 2 clinical trials, with offices in Westlake Village, California and Guangzhou, China.
Summary
Angitia Biopharmaceuticals is a Biotech company based in Westlake Village, United States, founded in 2018. It has raised $420.0M in total across 5 rounds, most recently a $130.0M Series D round in Feb 2026. Investors include Morningside Group, Frazier Life Sciences and Venrock.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...